12
Views
5
CrossRef citations to date
0
Altmetric
Articles

Staurosporine Increases Carcinoembryonic Antigen Expression in a Human Colon Cancer Cell Line

Pages 167-172 | Published online: 18 Jul 2013

REFERENCES

  • Maas IW, Boven E, Pinedo HM, Schluper HM, Haisma HJ. The effects of -y-interferon combined with 5-fluorouracil or 5-fluoro-2'-deoxyuridine on proliferation and antigen expres-sion in a panel of human colorectal cancer cell lines. Int J Cancer 1991; 48: 749–756.
  • Guadagni F, Witt PL, Robbins PF, Schlom J, Greiner JW. Regulation of carcinoembryonic antigen expression in dif-ferent human colorectal tumor cells by interferon-gamma. Cancer Res 1990; 50: 6248–6255.
  • De Filippi R, Prete SP, Giuliani A, et al. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononu-clear cells. Anticancer Res 1994; 14: 1767-1773.
  • Prete SP, Aquino A, Masci G, et al. Drug-induced changes of carcinoembryonic antigen expression in human cancer cells: effect of 5-fluorouracil. J Pharmacol Exp Ther 1996; 279: 1574-1581.
  • Aquino A, Prete SP, Greiner JW, et al. Effect of the combined treatment with 5-fluorouracil, gamma-interferon or folinic acid on carcinoembryonic antigen expression in colon cancer cells. Clin Cancer Res 1998; 4: 2473-2481.
  • Liefers GJ, Cleton-Janes AM, Van de Velde CJH, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339: 223–228.
  • Castells A, Boix L, Bessa X, Gargallo L, Pique JM. Detection of colonic cells in peripheral blood of colorectal can-cer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 1998; 78: 1368–72.
  • Greiner JW, Guadagni F, Noguchi P, et al. Recombinant interferon enhances monoclonal antibody-target-ing of carcinoma lesions in vivo. Science 1987; 235: 895–898.
  • Greiner JW, Ullmann CD, Nieroda C, et al. Improved radioimmunotherapeutic efficacy of an anticarcinoma mono-clonal antibody (131I-CC49) when given in combination with gamma-Interferon. Cancer Res 1993; 53: 600–608.
  • Tsanf KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 1995; 87: 982–990.
  • Cole DJ, Wilson MC, Baron PL, et al. Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum Gene Ther 1996; 7: 1381–1394.
  • Foon KA, John WJ, Chakraborty M, et al. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Clin Cancer Res 1997; 3: 1267–1276.
  • Tamaoki T, Nomoto H, Takahashi I, Kato Y, Morimoto M, Tomita F. Staurosporine, a potent inhibitor of phospho-lipid/Ca++ dependent protein kinase. Biochem Biophys Res Commun 1986; 135; 397–402.
  • Yoshizawa S, Fujiki H, Suguri H, et al. Tumor-promot-ing activity of staurosporine, a protein kinase inhibitor, in mouse skin. Cancer Res 1990; 50: 4974–4978.
  • Courage C, Budworth J, Gescher A. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localization. Br J Cancer 1995; 71: 697–704.
  • Chakrabarty S, Chen J W-J, Chen XYI. Modulation of differentiation-related responses in human colon carcinoma cells by protein kinase inhibitor H-7. Anticancer Res 1992; 12: 97–104.
  • Yoshimura M, Nishikawa A, Nishiura T, et al. Cell spreading in Cob 201 by staurosporin is alpha 3 beta 1 inte-grin-mediated with tyrosine phosphorylation of src and tensin. J Biol Chem 1995; 270: 2298-2304.
  • Yoshioka T, Masuko T, Kotanagi H, et al. Homotypic adhesion through carcinoembryonic antigen plays a role in hepatic metastasis development. Jpn J Cancer Res 1998; 89; 177–185.
  • Babia T, Veldman RJ, Hoekstra D, KoK JW. Modulation of carcinoembryonic antigen release by glucosylce-ramide-implications for HT29 cell differentiation. Eur J Biochem 1998; 258: 233–242.
  • Muraro R, Wonderlich D, Thor A, et al. Definition of monoclonal antibodies of a repertoire of epitopes on carci-noembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res 1985; 45: 5769–5780.
  • Gurley LR, Umbarger KO, Kim JM, Bradbury EM, Lehnert BE. High-performance liquid chromatographic analy-sis of staurosporine in vivo. Its traslocation and pharmacoki-netics in rats. J Chromatogr B Biomed Sci Appl 1998; 712: 211–224.
  • Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein Kinase C. Science 1992; 258: 607–614.
  • Gescher A. Towards selective pharmacological modula-tion of protein kinase C - opportunities for the development of novel antineoplastic agents. Br J Cancer 1992; 66: 10–19.
  • Akinaga S, Gomi K, Morimoto M, Tamaoki T, Okabe M. Antitumor Activity of UCN-01, a selective inhibitor of protein Kinase C, in murine and human tumor models. Cancer Res 1992; 51: 4888-4892.
  • Begemann M, Kashimawo SA, Lunn RM, et al. Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase. Anticancer Res 1998; 18: 3139-3152.
  • Nishi K, Schnier JB, Bradbury EM. The accumulation of cyclin-dependent kinase inhibitor p27kip 1 is a primary response to staurosporine and independent of G1 cell cycle arrest. Exp Cell Res 1998; 243: 222–231
  • Qiao L, Koutson M, Tsai L, et al. Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon carcinoma cells. Cancer Lett 1996; 107: 83–89.
  • Guadagni F, Witt PL, Robbins PF, Schlom J, Greiner JW. Regulation of carcinoembryonic antigen expression in dif-ferent human colorectal tumor cells by interferon-gamma. Cancer Res 1990; 50: 6248–6255.
  • Niles RM, Wilhem SA, Thomas P, Zamcheck N. The effect of sodium butyrate and retinoic acid on growth and CEA production in a series of human colorectal tumor cell lines representing different states of differentiation. Cancer Invest 1988; 6: 39–45.
  • Wang H, Rajagopal S, Reynolds S, Cederberg H, Chakrabarty S. Differentiation-promoting effect of 1-0(2 methoxy) hexadecyl glycerol in human colon cancer cells. J Cell Physiol 1999; 178: 173–178.
  • Yeatman TJ, Mao W, Karl RC. Biliary glycoprotein is overexpressed in human colon cancer cells with high metastat-ic potential. J Gastrointest Surg 1997; 1: 292–298.
  • Chakrabarty S, Rajagopal S, Moskal TL. Protein kinase C alpha controls the adhesion but not the antiproliferative response of human colon carcinoma cells to transforming growth factor beta 1: identification of two distinct branches of post-protein kinase C alpha adhesion signal pathway. Lab Invest 1998; 4: 413–421.
  • Chakrabarty S, Huang S. Role of protein kinase C alpha in the induction of carcinoembryonic antigen by trans-forming growth factor beta 1. J Cell Phisiol 1995; 164: 148–153.
  • Chakrabarty S. Role of protein kinase C in transform-ing factor-beta 1 induction of carcinoembryonic antigen in human colon carcinoma cells. J Cell Phisiol 1992; 152: 494–499.
  • Sausville EA, Lush RD, Headlee D, et al. Clinical phar-macology of UCN-01: initial observations and comparison to preclinical models. Cancer Chemother Pharmacol 1998; 42 (Suppll S54-S59.
  • Futamura M, Takagi Y, Koumura H, et al. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carci-noembryonic antigen and cytokeratin 20. J Surg Oncol 1998; 68: 34–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.